News

WHAT KRAS MEANS AND WHY IT MATTERS KRAS is what scientists call an oncogene – a gene that, when mutated, can promote uncontrolled cell growth and lead to cancer. In […]

COLD SPRING HARBOR, N.Y., Oct 10, 2025 – The Lustgarten Foundation, the world’s largest private funder of pancreatic cancer research, convened its annual Scientific Advisory Board (SAB) Meeting on October […]

25th Annual Long Island Walk presented by Northwell Health Cancer Institute draws nearly 3,000 supporters & raises more than $826,000 and counting in support of pancreatic cancer research JONES BEACH, […]

Federal funding cuts to cancer research are devastating—but we’re not giving up, and neither should you! Know the facts – Why it matters and who it hurts – In moments […]

UNIONDALE, NY, Sep 15, 2025 — The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, today announced a landmark year of funding, awarding ten new grants to […]

This week, Exact Sciences announced the launch of Cancerguard™, a new blood-based multi-cancer early detection (MCED) test now available as a laboratory-developed test (LDT) in the U.S., priced at $689. […]

The results of the Pancreatic Adenocarcinoma Signature Stratification for Treatment (PASS-01) clinical trial were published today in the Journal of Clinical Oncology, marking a major milestone in the pursuit of […]

A new clinical trial is generating headlines — and hope — for people facing pancreatic cancer. In a Phase 1 study published in Nature Medicine, researchers tested an “off-the-shelf” cancer […]